SYN-TECH Chem. & Pharm. Co., Ltd. (TPEX:1777)

Taiwan · Delayed Price · Currency is TWD

72.40

0.00 (0.00%)

Jun 18, 2026, 1:30 PM CST

-16.20% (1Y)

Market Cap	3.23B -19.6%
Revenue (ttm)	1.26B -3.3%
Net Income	257.51M -32.5%
EPS	5.75 -32.7%
Shares Out	44.59M
PE Ratio	12.59
Forward PE	n/a
Dividend	4.00 (5.52%)
Ex-Dividend Date	Jul 16, 2026

Volume	9,744
Open	72.20
Previous Close	72.40
Day's Range	72.20 - 72.60
52-Week Range	70.00 - 88.40
Beta	-0.06
Analysts	Hold
Price Target	87.00 (+20.17%)
Earnings Date	Aug 6, 2026

About SYN-TECH Chem. & Pharm.

SYN-TECH Chem. & Pharm. Co., Ltd. manufactures and sells active pharmaceutical ingredients (APIs) in Taiwan, Asia, Europe, the Americas, and internationally. The company offers test drugs and surfactants, as well as various Chinese, Western, and animal medicines. It also provides products in various categories, such as anticoagulant, attention deficit hyperactivity disorder, skeletal muscle relaxant, antitussive, antipruritic, scabicide, anti-inflammatory, antipyretic, analgesic, muscle relaxant, anxiolytic, antiemetic, anticonvulsant, anti-ulc... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1982

Employees 223

Stock Exchange Taipei Exchange

Ticker Symbol 1777

Full Company Profile

Financial Performance

In 2025, SYN-TECH Chem. & Pharm.'s revenue was 1.30 billion, an increase of 3.39% compared to the previous year's 1.26 billion. Earnings were 261.61 million, a decrease of -33.48%.

Financial Statements